Healthcare provider profile · identity verified

Charles D Fowler, MD

Internal Medicine · ATLANTA, GA · NPI 1568566925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	601	199
Amlodipine Besylate	Amlodipine Besylate	458	166
Losartan Potassium	Losartan Potassium	352	113
Gabapentin	Gabapentin	285	104
Potassium Chloride	Potassium Chloride	251	85
Rosuvastatin Calcium	Rosuvastatin Calcium	251	90
Montelukast Sodium	Montelukast Sodium	239	96
Nabumetone	Nabumetone	224	80
Tamsulosin Hcl	Tamsulosin Hcl	224	79
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	210	49
Lisinopril	Lisinopril	209	70
Pantoprazole Sodium	Pantoprazole Sodium	195	64
Metformin Hcl Er	Metformin Hcl	188	72
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	187	63
Albuterol Sulfate Hfa	Albuterol Sulfate	170	85
Hydrochlorothiazide	Hydrochlorothiazide	169	55
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	162	25
Furosemide	Furosemide	153	54
Glipizide	Glipizide	151	54
Metoprolol Succinate	Metoprolol Succinate	151	53
Allopurinol	Allopurinol	146	43
Jardiance	Empagliflozin	146	29
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	134	42
Metformin Hcl	Metformin Hcl	129	41
Meloxicam	Meloxicam	120	45
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	117	39
Levothyroxine Sodium	Levothyroxine Sodium	117	38
Humulin N	Insulin Nph Human Isophane	111	34
Tramadol Hcl	Tramadol Hcl	109	47
Trazodone Hcl	Trazodone Hcl	109	48
Hydralazine Hcl	Hydralazine Hcl	101	37
Carvedilol	Carvedilol	97	34
Simvastatin	Simvastatin	97	35
Glimepiride	Glimepiride	93	29
Prednisone	Prednisone	85	64
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	85	27
Duloxetine Hcl	Duloxetine Hcl	83	27
Trospium Chloride	Trospium Chloride	83	28
Pravastatin Sodium	Pravastatin Sodium	82	30
Atenolol	Atenolol	81	27
Alendronate Sodium	Alendronate Sodium	80	28
Omeprazole	Omeprazole	77	28
Alvesco	Ciclesonide	74	22
Venlafaxine Hcl Er	Venlafaxine Hcl	73	31
Lidocaine-Prilocaine	Lidocaine/Prilocaine	71	28
Spironolactone	Spironolactone	70	25
Famotidine	Famotidine	68	21
Mirtazapine	Mirtazapine	67	28
Wixela Inhub	Fluticasone Propion/Salmeterol	67	21
Finasteride	Finasteride	65	20
Metoprolol Tartrate	Metoprolol Tartrate	63	25
Mupirocin	Mupirocin	61	37
Humulin R	Insulin Regular, Human	60	17
Ondansetron Odt	Ondansetron	60	24
Pradaxa	Dabigatran Etexilate Mesylate	60	22
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	60	16
Arexvy	Rsvpref3 Antigen/As01e/Pf	55	54
Fluticasone Propionate	Fluticasone Propionate	55	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	17
Clopidogrel	Clopidogrel Bisulfate	52	16
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Felodipine Er	Felodipine	48	14
Lovastatin	Lovastatin	48	13
Pregabalin	Pregabalin	45	15
Methylprednisolone	Methylprednisolone	44	40
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	41
Bupropion Xl	Bupropion Hcl	42	15
Doxazosin Mesylate	Doxazosin Mesylate	41	13
Ipratropium Bromide	Ipratropium Bromide	41	13
Colchicine	Colchicine	40	17
Lactulose	Lactulose	40	14
Desonide	Desonide	39	14
Levetiracetam	Levetiracetam	39	13
Latanoprost	Latanoprost	38	20
Verapamil Er	Verapamil Hcl	38	suppressed
Nystatin	Nystatin	37	15
Eliquis	Apixaban	36	12
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Fluconazole	Fluconazole	35	23
Hydrocortisone	Hydrocortisone	35	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	35	11
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	34	34
Bisoprolol Fumarate	Bisoprolol Fumarate	34	suppressed
Nifedipine Er	Nifedipine	33	13
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	32	suppressed
Indapamide	Indapamide	31	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	12
Calcitriol	Calcitriol	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	26	23
Triamcinolone Acetonide	Triamcinolone Acetonide	26	26
Sertraline Hcl	Sertraline Hcl	25	12
Veo Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	24	suppressed
Cilostazol	Cilostazol	23	suppressed
Fentanyl	Fentanyl	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Torsemide	Torsemide	23	12
Warfarin Sodium	Warfarin Sodium	23	suppressed
Cefuroxime	Cefuroxime Axetil	21	17
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Clonidine Hcl	Clonidine Hcl	17	suppressed
Creon	Lipase/Protease/Amylase	17	suppressed
Digoxin	Digoxin	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	16	11
Sucralfate	Sucralfate	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Naloxone Hcl	Naloxone Hcl	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	13	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ozempic	Semaglutide	12	suppressed
Darifenacin Er	Darifenacin Hydrobromide	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Febuxostat	Febuxostat	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Metolazone	Metolazone	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error